Huntingtin-associated protein-1 is a modifier of the age-at-onset of Huntington's disease

Human Molecular Genetics

Volumn 17, Issue 8, 2008, Pages 1137-1146

  Metzger, Silke ^a   Rong, Juan ^b   Nguyen, Huu Phuc ^a   Cape, Austin ^b   Tomiuk, Juergen ^a   Soehn, Anne S ^a   Propping, Peter ^c   Freudenberg hua, Yun ^c   Freudenberg, Jan ^d   Tong, Liang ^e   Li, Shi Hua ^b   Li, Xiao Jiang ^b   Riess, Olaf ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF BONN   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; HUNTINGTIN; HUNTINGTIN ASSOCIATED PROTEIN 1; METHIONINE; MUTANT PROTEIN; THREONINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CHILD; CONTROLLED STUDY; DNA MODIFICATION; EUROPE; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; ONSET AGE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; CHILD; CHILD, PRESCHOOL; HUMANS; HUNTINGTON DISEASE; MIDDLE AGED; MUTATION, MISSENSE; NERVE TISSUE PROTEINS; POLYMORPHISM, GENETIC; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRINUCLEOTIDE REPEATS;

EID: 41849097772     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddn003     Document Type: Article

References (56)

1. Hayden, M.R. (1991) Huntington's Chorea. Springer, New York, NY.
2. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is unstable on Huntington's disease chromosomes. Cell, 26, 971-983.
3. Andrew, S.E., Goldberg, Y.P., Kremer, B., Telenius, H., Theilmann, J., Adam, S., Starr, E., Squitieri, F., Lin, B., Kalchman, M.A. et al. (1993) The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat. Genet., 4, 398-403.
4. Snell, R.G., MacMillan, J.C., Cheadle, J.P., Fenton, I., Lazarou, L.P., Davies, P., MacDonald, M.E., Gusella, J.F., Harper, P.S. and Shaw, D.J. (1993) Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat. Genet, 4, 393-397.
5. Duyao, M., Ambrose, C., Myers, R., Noveletto, A., Persichetti, F., Frontali, M., Folstein, S., Ross, C., Franz, M., Abbott, M. et al. (1993) Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat. Genet., 4, 387-392.
6. Zühlke, C., Riess, O., Schröder, K., Siedlaczek, I., Epplen, J.T., Engel, W. and Thies, U. (1993) Expansion of the (CAG)n repeat causing Huntington's disease in 352 patients of German origin. Hum. Mol. Genet., 2, 1467-1469.
7. Brinkman, R.R., Mezei, M.M., Theilmann, J., Almqvist, E. and Hayden, M.R. (1997) The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. Am. J. Hum Genet., 60, 1202-1210.
8. Lucotte, G., Turpin, J.C., Riess, O., Epplen, J.T., Siedlaczk, I., Loirat, F. and Hazout, S. (1995) Confidence intervals for predicted age of onset, given the size of (CAG)n repeat, in Huntington's disease. Hum. Genet., 95, 231-232.
9. The U.S.-Venezuela Collaborative Research Project and Wexler, N.S. (2004) Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc. Natl Acad. Sci. USA 9, 3498-3503.
10. Rosenblatt, A., Brinkman, R.R., Liang, K.Y., Almqvist, E.W., Margolis, R.L., Huang, C.Y., Sherr, M., Franz, M.L., Abbott, M.H., Hayden, M.R. et al. (2001) Familial influence on age of onset among siblings with Huntington's disease. Am. J. Med. Genet., 105, 399-403.
11. Li, J.L., Hayden, M.R., Almqvist, E.W., Brinkman, R.R., Durr, A., Dode, C., Morrison, P.J., Suchowersky, O., Ross, C.A., Margolis, R.L. et al. (2003) A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS study. Am. J. Hum. Genet., 73, 682-687.
12. Li, J.L., Hayden, M.R., Warby, S.C., Durr, A., Morrison, P.J., Nance, M., Ross, C.A., Margolis, R.L., Rosenblatt, A., Squitieri, F. et al. (2006) Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: The HD MAPS study. BMC Med. Genet., 7, 71.
13. Vuillaume, I., Vermersch, P., Destee, A., Petit, H. and Sablonniere, B. (1998) Genetic polymorphisms adjacent to the CAG repaet influence clinical features at onset in Huntington's disease. J. Neurol. Neurosurg. Psychiatry, 64, 758-162.
14. Djoussé, L., Knowlton, B., Hayden, M.R., Almqvist, E.W., Brinkman, R., Ross, C., Margolis, R., Rosenblatt, A., Durr, A., Dode, C. et al. (2003) Interaction of normal and expanded repeat sizes influences age at onset of Huntington disease. Am. J. Med. Genet. A, 119, 279-282.
15. Kehoe, P., Krawczak, M., Harper, P.S., Owen, M.J. and Jones, A.L. (1999) Age of onset in Huntington disease: Sex specific influence of apolipoprotein E genotype and normal CAG repeat length. J. Med. Genet., 36, 108-111.
16. Andresen, J.M., Gayah, J., Cherny, S.S., Brocklebank, D., Alkorta-Aranburu, G., Addis, E.A., Cardon, L.R., Housman, D.E., Wexler, N.S. and and The US-Venezuela Collaborative Research Group (2007) Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds. J. Med. Genet. 44, 44-50.
17. Djousse, L., Knowlton, B., Hayden, MR, Almqvist, E.W., Brinkman, R.R., Ross, C.A., Margolis, R.L., Rosenblatt, A., Durr, A., Dode, C. et al. (2004) Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16. Neurogenetics, 5, 109-114.
18. Rubinsztein, D.C., Leggo, J., Chiano, M., Dodge, A., Norbury, G, Rosser, E. and Craufurd, D. (1997) Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease. Proc. Natl Acad. Sci. USA, 94, 3872-3876.
19. Arning, L., Kraus, P.H., Valentin, S., Saft, C., Andricj, J. and Epplen, J.T. (2005) NR2A and NR2B receptor gene variations modify age at onset in Huntington disease. Neurogenetics, 6, 25-28.
20. Metzger, S., Bauer, P., Tomiuk, J., Laccone, F., Didonato, S., Gellera, C., Soliveri, P., Lange, H.W., Weirich-Schwaiger, H., Wenning, G.K. et al. (2005) The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease. Neurogenetics, 7, 27-30.
21. Naze, P., Vuillaume, I., Destee, A., Pasquier, F. and Sablonniere, B. (2002) Mutation analysis and association studies of the ubiquitin carboxy-terminal hydrolase L1 gene in Huntington's disease. Neurosci. Lett., 328, 1-4.
22. Metzger, S., Bauer, P., Tomiuk, J., Laccone, F., Didonato, S., Gellera, C., Mariotti, C., Lange, H.W., Weirich-Schwaiger, H., Wenning, G.K. et al. (2006) Genetic analysis of candidate genes modifying the age-at-onset in Huntington's disease. Hum. Genet., 120, 285-292.
23. Li, X.J., Li, S.H., Sharp, A.H., Nucifora, F.C., Jr.; Schilling, G., Lanahan, A., Worley, P., Snyder, S.H. and Ross, C.A. (1995) A huntingtin-associated protein enriched in brain with implications for pathology. Nature, 378, 398-402.
24. Gutekunst, C.A., Li, S.H., Yi, H., Ferrante, R.J., Li, X.J. and Hersch, S.M. (1998) The cellular and subcellular localization of huntingtin-associated protein 1 (HAP1): Comparison with huntingtin in rat and human. J. Neurosci., 18, 7674-7686.
25. Engelender, S., Sharp, A.H., Colomer, V., Tokito, M.K., Lanahan, A., Worley, P., Holzbaur, E.L. and Ross, C.A. (1997) Huntingtin-associated protein 1 (HAP1) interacts with the p15OGlued subunit of dynactin. Hum. Mol. Genet., 6, 2205-2212.
26. McGuire, J.R., Rong, J., Li, S.H. and Li, X.J. (2006) Interaction of Huntingtin-associated protein-1 with kinesin light chain: Implications in intracellular trafficking in neurons. J. Biol. Chem., 281 3552-3559.
27. Tang, T.S., Tu, H., Chan, E.Y., Maximov, A., Wang, Z., Wellington, C.L., Hayden, M.R. and Rezprozvanny, I. (2003) Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate roceptor type 1. Neuron, 39, 227-239.
28. Takeshita, Y., Fujinaga, R., Zhao, C., Yanai, A. and Shinoda, K. (2006) Huntingtin-associated protein 1 (HAP1) interacts with androgen receptor (AR) and suppresses SBMA-mutant-AR-induced apoptosis. Hum. Mol. Genet., 15, 2298-2312.
29. Gauthier, L.R., Charrinm, B.C., Borrell-Pages, M., Dompierrem, J.P., Rangone, H., Cordelieres, F.P., De Mey, J., MacDonald, M.E., Eessmann, V., Humbert, S. et al. (2004) Huntingtirr controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along micrombules. Cell, 118, 127-138.
30. Block-Galarza, J., Chase, K.O., Sapp, E., Vaughn, K.T., Vallee, R.B., DiFiglia, M. and Aronin, N. (1997) Fast transport and retrograde movement of huntingtin and RAP1 in axons. Neuroreport, 8, 2247-2251.
31. Li, S.H., Hosseini, S.H., Gutekunst, C.A., Hersch, S.M., Ferrante, R.J. and Li, X.J. (1998) A human HAP1 homologne. Cloning, expression, and interaction with huntingtin. J. Biol. Chem., 273, 19220-19227.
32. Colomer, V., Engelender, S., Sharp, A.H., Duan, K., Cooper, J.K., Lanahan, A., Lyford, G., Worley, P. and Ross, C.A. (1997) Huntingtin-associated protein 1 (HAP1) binds to a Trio-like polypeptide, with a rac1 guanine nucleotide exchange factor domain. Hum. Mol. Genet., 6, 1519-1525.
33. Li, S.-H., Gutekunst, C.A., Hersch, S.M. and Li, X.J. (1998) Interaction of huntingtin-associated protein with dynactin P150Glued. J. Neurosci., 18, 1261-1269.
34. Gutekunst, C.A., Li, S.H., Yi, H., Mulroy, J.S., Kuemmerle, S., Jones, R., Rye, D., Ferrante, R.J., Hersch, S.M. and Li, J. (1999) Nuclear and neuropil aggregates in Huntington's disease: Relationship to neuropathology. J. Neurosci., 19, 2522-2534.
35. Nance, M.A. and Myers, R.H. (2001) Juvenile onset Huntington's disease - clinical and research perspectives. Ment. Retard. Dev. Disabil. Res. Rev., 7, 153-157.
36. Li, X-J. and Li, H. (2005) HAP1 and intracellular trafficking. Trends Pharmacol. Sci., 26, 1-3.
37. Li, Y., Chin, L.S., Levey, A.I. and Li, L. (2002) Huntingtin-associated protein 1 interacts with hepatocyte growth factor-regulated tyrosine kinase substrate and functions in endosomal trafficking. J. Biol. Chem., 277, 28212-28221.
38. Li, S.H., Yu, Z.X., Li, C.L., Nguyen, H.P., Zhou, Y.X., Deng, C. and Li, X.J. (2003) Lack of huntingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington's disease. J. Neurosci., 23, 6956-6964.
39. Fujinaga, R., Kawano, J., Matsuzaki, Y., Kamei, K., Yanai, A., Sheng, Z., Tanaka, M., Nakahama, K., Nagano, M. and Shinoda, K. (2004) Neuroanatomical distribution of Huntingtin-associated protein 1-mRNA in the male mouse brain. J Comp. Neurol., 478, 88-109.
40. Zucker, B., Luthi-Carter, R., Kama, J.A., Dunah, A.W., Stem, E.A., Fox, J.H., Standaerd, D.G., Young, A.B. and Augood, S.J. (2005) Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: Neuronal selectivity and potential neuroprotective role of HAP1. Hum. Mol. Genet., 14 179-189.
41. DiFiglia, M., Sapp, E., Chase, K.O., Davies, S.W., Bates, G.P., Vonsattel, J.P. and Aronin, N. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science, 277, 1990-1993.
42. Arrasate, M., Mitra, S., Schweitzer, E.S., Segal, M.R. and Finkbeiner, S. (2004) Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature, 431, 805-810.
43. Wellington, C.L., Singaraja, R., Ellerby, L., Savill, J., Roy, S., Leavitt, B., Cattaneo, E., Hackam, A., Sharp, A., Thornberry, N. et al. (2000) Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. J. Biol. Chem., 275, 19831-19838.
44. Gafni, J. and Ellerby, L.M. (2002) Calpain activation in Huntington's disease. J. Neurosci., 22, 4842-4849.
45. Graham, R.K., Deng, Y., Slow, E., Haigh, B., Bissada, N., Lu, G., Pearson, J., Shehadeh, J., Bertram, L. and Murphy, Z. (2006) Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell, 125, 1179-1191.
46. Zeron, M.M., Chen, N., Moshaver, A., Lee, A.T., Wellington, C.L., Hayden, M.R. and Raymond, L.A. (2001) Mutant huntingtin enhances excitotoxic cell death. Mol. Cell. Neurosci., 17, 41-53.
47. Polidori, M.C., Mecocci, P., Browne, S.E., Senin, U. and Beal, M.F. (1999) Oxidative damage to mitochondrial DNA in Huntington's disease parietal cortex. Neurosci. Lett., 272, 53-56.
48. Zuccato, C., Tartari, M., Crotti, A., Goffredo, D., Valenza, M., Conti, L., Cataudella, T., Leavitt, B.R., Hayden, M.R., Timmusk, T. et al. (2003) Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat. Genet., 35, 76-83.
49. Li, S. and Li, X.J. (2006) Multiple pathways contribute to the pathogenesis of Huntington disease. Mol. Neurodegener., 1, 19.
50. Duyao, M.P., Auerbach, A.B., Ryan, A., Persichetti, F., Barnes, G.T., McNeil, S.M., Ge, P., Vonsattel, J.P., Gusella, J.F., Joyner, A.L. et al. (1995) Inactivation of the mouse Huntington's disease gene homolog Hdh. Science, 269, 407-410.
51. Landles, C. and Bates, G.P. (2004) Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series. EMBO Rep., 5, 958-963.
52. Li, X.-J., Friedman, M. and Li, S. (2007) Interacting proteins as genetic modifiers of Huntington's disease. Trends Genet., 23 531-533.
53. Alberch, J., Lopez, M., Badenas, C., Carrasco, J.L., Mila, M., Munoz, E. and Canals, J.M. (2005) Association between BDNF Val66Met polymorphism and age at onset in Huntington disease. Neurology, 65, 964-965.
54. Rong, J., McGuire, J.R., Fang, Z.H., Sheng, G., Shin, J.Y., Li, S.H. and Li, X.J. (2006) Regulation of intracellular trafficking of hungtingtin-associated protein-1 is critical for TrkA protein levels and neurite outgrowth. J. Neurosci., 26, 6019-6030.
55. Kittler, J.T., Thomas, P., Tretter, V., Bogdanov, Y.D., Haucke, V., Smart, T.G. and Moss, S.J. (2004) Huntingtin-associated protein 1 regulates inhibitory synaptic transmission by modulating gamma-aminobutyric acid type A receptor membrane trafficking. Proc. Natl Acad. Sci. USA, 101, 12736-12741.
56. den Dunnen, J.T. and Antonarakis, S.E. (2001) Nomenclature for the description of human sequence variations. Hum. Genet., 109, 121-124.